Recent large-scale proteomic studies reveal the association of levels of circulating proteins with life span and many health-related outcomes.
References
Villeda, S. A. et al. Nature 477, 90–94 (2011).
Conboy, I. M. et al. Nature 433, 760–764 (2005).
Nakamura, A. et al. Nature 554, 249–254 (2018).
Dodgson, S. E. Cell 173, 1–3 (2018).
Cohen, J. D. et al. Science 359, 926–930 (2018).
Emilsson, V. et al. Science 361, 769–773 (2018).
Sun, B. B. et al. Nature 558, 73–79 (2018).
Lehallier, B., Gate, D., Schaum, N. & Nanasi, T. Nat. Med. https://doi.org/10.1038/s41591-019-0673-2 (2019).
Williams, S. A., Kivimaki, M., Langenberg, C. & Hingorani, A. D. Nat. Med. https://doi.org/10.1038/s41591-019-0665-2 (2019).
Middeldorp, J. et al. JAMA Neurol. 73, 1325–1333 (2016).
Sherman, R. E. et al. N. Engl. J. Med. 375, 2293–2297 (2016).
Schadt, E. E. Nature 461, 218–223 (2009).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
L.L.J. is an employee and stockholder of Novartis. V.E. and V.G. declare no competing interests.
Rights and permissions
About this article
Cite this article
Emilsson, V., Gudnason, V. & Jennings, L.L. Predicting health and life span with the deep plasma proteome. Nat Med 25, 1815–1816 (2019). https://doi.org/10.1038/s41591-019-0677-y
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41591-019-0677-y
- Springer Nature America, Inc.
This article is cited by
-
Coding and regulatory variants are associated with serum protein levels and disease
Nature Communications (2022)
-
A proteogenomic signature of age-related macular degeneration in blood
Nature Communications (2022)
-
Translational precision medicine: an industry perspective
Journal of Translational Medicine (2021)